IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Olsen, T. W.
Right arrow Articles by Geroski, D. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Olsen, T. W.
Right arrow Articles by Geroski, D. H.

Investigative Ophthalmology & Visual Science, Vol 36, 1893-1903, Copyright © 1995 by Association for Research in Vision and Ophthalmology

ARTICLES AND REPORTS

Human scleral permeability. Effects of age, cryotherapy, transscleral diode laser, and surgical thinning

TW Olsen, HF Edelhauser, JI Lim and DH Geroski
Department of Ophthalmology, Emory University, Atlanta, GA 30322, USA.

PURPOSE. To determine the in vitro permeability of human sclera to compounds varying in molecular weight. To evaluate the effects of age, cryotherapy, transscleral diode laser, and surgical thinning on scleral permeability. METHODS: Scleral tissue from 97 human eye bank eyes was tested individually in a two-chamber Ussing apparatus with the following hydrophilic radiolabeled compounds on one side of the chamber: 5-fluorouracil, sucrose, dexamethasone, methotrexate, inulin, and three separate dextran polymers (MWt = 10,000, 40,000, and 70,000). Scleral hydration levels were obtained on 20 more scleral specimens. Additional groups of scleral specimens were treated with either a cryotherapy probe, a transscleral diode laser retinopexy probe, or partial thickness lamellar dissection, and specimens were mounted in the Ussing chambers for testing. Scleral tissue was digested to measure the amount of radioactivity present. Scleral sections were examined with electron microscopy. RESULTS. Scleral hydration was maintained during the perfusion. The mean scleral permeability (cm/second x 10(-6) +/- SD) was established for each of the above compounds. Age, cryotherapy, or diode laser treatment did not alter permeability or ultrastructure of the sclera. Surgical thinning significantly increased the scleral permeability to dexamethasone (P = 0.011) and methotrexate (P = 0.037). CONCLUSION. This study establishes baseline human scleral permeability to a series of hydrophilic compounds with various molecular weights. Age, cryotherapy, and diode laser treatment do not alter the permeability or ultrastructure of the sclera, whereas surgical thinning significantly increases permeability.


This article has been cited by other articles:


Home page
 IOVSHome page
S. S. Palii, A. Afzal, L. C. Shaw, H. Pan, S. Caballero, R. C. Miller, S. Jurczyk, J.-C. Reubi, Y. Tan, G. Hochhaus, et al.
Nonpeptide Somatostatin Receptor Agonists Specifically Target Ocular Neovascularization via the Somatostatin Type 2 Receptor
Invest. Ophthalmol. Vis. Sci., November 1, 2008; 49(11): 5094 - 5102.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
O. A. Anderson, T. L. Jackson, J. K. Singh, A. A. Hussain, and J. Marshall
Human Transscleral Albumin Permeability and the Effect of Topographical Location and Donor Age
Invest. Ophthalmol. Vis. Sci., September 1, 2008; 49(9): 4041 - 4045.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
J. Y. Tsui, C. Dalgard, K. R. Van Quill, L. Lee, H. E. Grossniklaus, H. F. Edelhauser, and J. M. O'Brien
Subconjunctival Topotecan in Fibrin Sealant in the Treatment of Transgenic Murine Retinoblastoma
Invest. Ophthalmol. Vis. Sci., February 1, 2008; 49(2): 490 - 496.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
G. Zhang, X. Feng, K. Wabner, C. Fandrey, A. Naqwi, T. Wiedmann, and T. W. Olsen
Intraocular Nanoparticle Drug Delivery: A Pilot Study Using an Aerosol during Pars Plana Vitrectomy
Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 5243 - 5249.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
J. D. Lindsey, J. G. Crowston, A. Tran, C. Morris, and R. N. Weinreb
Direct Matrix Metalloproteinase Enhancement of Transscleral Permeability
Invest. Ophthalmol. Vis. Sci., February 1, 2007; 48(2): 752 - 755.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
S. H. Kim, C. J. Galban, R. J. Lutz, R. L. Dedrick, K. G. Csaky, M. J. Lizak, N. S. Wang, G. Tansey, and M. R. Robinson
Assessment of Subconjunctival and Intrascleral Drug Delivery to the Posterior Segment Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging
Invest. Ophthalmol. Vis. Sci., February 1, 2007; 48(2): 808 - 814.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
J. Jiang, D. H. Geroski, H. F. Edelhauser, and M. R. Prausnitz
Measurement and Prediction of Lateral Diffusion within Human Sclera.
Invest. Ophthalmol. Vis. Sci., July 1, 2006; 47(7): 3011 - 3016.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
J. Amaral, R. N. Fariss, M. M. Campos, W. G. Robison Jr, H. Kim, R. Lutz, and S. P. Becerra
Transscleral-RPE Permeability of PEDF and Ovalbumin Proteins: Implications for Subconjunctival Protein Delivery
Invest. Ophthalmol. Vis. Sci., December 1, 2005; 46(12): 4383 - 4392.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
X. Feng, K. Pilon, Y. Yaacobi, and T. W. Olsen
Extraocular Muscle Insertions Relative to the Fovea and Optic Nerve: Humans and Rhesus Macaque
Invest. Ophthalmol. Vis. Sci., October 1, 2005; 46(10): 3493 - 3496.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
L. P. J. Cruysberg, R. M. M. A. Nuijts, D. H. Geroski, J. A. Gilbert, F. Hendrikse, and H. F. Edelhauser
The Influence of Intraocular Pressure on the Transscleral Diffusion of High-Molecular-Weight Compounds
Invest. Ophthalmol. Vis. Sci., October 1, 2005; 46(10): 3790 - 3794.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
H M Brereton, S D Taylor, A Farrall, D Hocking, M A Thiel, M Tea, D J Coster, and K A Williams
Influence of format on in vitro penetration of antibody fragments through porcine cornea
Br. J. Ophthalmol., September 1, 2005; 89(9): 1205 - 1209.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
L. Pitkanen, V.-P. Ranta, H. Moilanen, and A. Urtti
Permeability of Retinal Pigment Epithelium: Effects of Permeant Molecular Weight and Lipophilicity
Invest. Ophthalmol. Vis. Sci., February 1, 2005; 46(2): 641 - 646.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
H. Kim, M. R. Robinson, M. J. Lizak, G. Tansey, R. J. Lutz, P. Yuan, N. S. Wang, and K. G. Csaky
Controlled Drug Release from an Ocular Implant: An Evaluation Using Dynamic Three-Dimensional Magnetic Resonance Imaging
Invest. Ophthalmol. Vis. Sci., August 1, 2004; 45(8): 2722 - 2731.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
A. Kato, H. Kimura, K. Okabe, J. Okabe, N. Kunou, and Y. Ogura
Feasibility of Drug Delivery to the Posterior Pole of the Rabbit Eye with an Episcleral Implant
Invest. Ophthalmol. Vis. Sci., January 1, 2004; 45(1): 238 - 244.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
K. Okabe, H. Kimura, J. Okabe, A. Kato, N. Kunou, and Y. Ogura
Intraocular Tissue Distribution of Betamethasone after Intrascleral Administration Using a Non-biodegradable Sustained Drug Delivery Device
Invest. Ophthalmol. Vis. Sci., June 1, 2003; 44(6): 2702 - 2707.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
J. Okabe, H. Kimura, N. Kunou, K. Okabe, A. Kato, and Y. Ogura
Biodegradable Intrascleral Implant for Sustained Intraocular Delivery of Betamethasone Phosphate
Invest. Ophthalmol. Vis. Sci., February 1, 2003; 44(2): 740 - 744.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
K. G. Carrasquillo, J. A. Ricker, I. K. Rigas, J. W. Miller, E. S. Gragoudas, and A. P. Adamis
Controlled Delivery of the Anti-VEGF Aptamer EYE001 with Poly(lactic-co-glycolic)Acid Microspheres
Invest. Ophthalmol. Vis. Sci., January 1, 2003; 44(1): 290 - 299.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
T. W. Olsen, S. Sanderson, X. Feng, and W. C. Hubbard
Porcine Sclera: Thickness and Surface Area
Invest. Ophthalmol. Vis. Sci., August 1, 2002; 43(8): 2529 - 2532.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
A. E. Simpson, J. A. Gilbert, D. E. Rudnick, D. H. Geroski, T. M. Aaberg Jr, and H. F. Edelhauser
Transscleral Diffusion of Carboplatin: An In Vitro and In Vivo Study
Arch Ophthalmol, August 1, 2002; 120(8): 1069 - 1074.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
T. W. Kim, J. D. Lindsey, M. Aihara, T. L. Anthony, and R. N. Weinreb
Intraocular Distribution of 70-kDa Dextran after Subconjunctival Injection in Mice
Invest. Ophthalmol. Vis. Sci., June 1, 2002; 43(6): 1809 - 1816.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
M. Aihara, J. D. Lindsey, and R. N. Weinreb
Enhanced FGF-2 Movement through Human Sclera after Exposure to Latanoprost
Invest. Ophthalmol. Vis. Sci., October 1, 2001; 42(11): 2554 - 2559.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
J.-W. Kim, J. D. Lindsey, N. Wang, and R. N. Weinreb
Increased Human Scleral Permeability with Prostaglandin Exposure
Invest. Ophthalmol. Vis. Sci., June 1, 2001; 42(7): 1514 - 1521.
[Abstract] [Full Text]

Home page
 Br. J. Ophthalmol.Home page
M A Thiel, N Morlet, D Schulz, H F Edelhauser, J K Dart, D J Coster, and K A Williams
A simple corneal perfusion chamber for drug penetration and toxicity studies
Br. J. Ophthalmol., April 1, 2001; 85(4): 450 - 453.
[Abstract] [Full Text]

Home page
 IOVSHome page
D. H. Geroski and H. F. Edelhauser
Drug Delivery for Posterior Segment Eye Disease
Invest. Ophthalmol. Vis. Sci., April 1, 2000; 41(5): 961 - 964.
[Full Text]

Home page
 IOVSHome page
J. Ambati, C. S. Canakis, J. W. Miller, E. S. Gragoudas, A. Edwards, D. J. Weissgold, I. Kim, F. C. Delori, and A. P. Adamis
Diffusion of High Molecular Weight Compounds through Sclera
Invest. Ophthalmol. Vis. Sci., April 1, 2000; 41(5): 1181 - 1185.
[Abstract] [Full Text]

Home page
 IOVSHome page
J. Ambati, E. S. Gragoudas, J. W. Miller, T. T. You, K. Miyamoto, F. C. Delori, and A. P. Adamis
Transscleral Delivery of Bioactive Protein to the Choroid and Retina
Invest. Ophthalmol. Vis. Sci., April 1, 2000; 41(5): 1186 - 1191.
[Abstract] [Full Text]

Home page
 IOVSHome page
D. E. Rudnick, J. S. Noonan, D. H. Geroski, M. R. Prausnitz, and H. F. Edelhauser
The Effect of Intraocular Pressure on Human and Rabbit Scleral Permeability
Invest. Ophthalmol. Vis. Sci., November 1, 1999; 40(12): 3054 - 3058.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
N. J. Anderson, W. D. Woods, T. Kim, D. E. Rudnick, and H. F. Edelhauser
Intracameral Anesthesia: In Vitro Iris and Corneal Uptake and Washout of 1% Lidocaine Hydrochloride
Arch Ophthalmol, February 1, 1999; 117(2): 225 - 232.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the Association for Research in Vision and Ophthalmology